CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes

CXCR3/Ligands Are Significantly Involved in the Tumorigenesis of Basal Cell Carcinomas

(2010) Blanche Ka Ki Lo et al.   AMERICAN JOURNAL OF PATHOLOGY

Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune Privilege

(2010) Lei Huang et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells

(2010) Ting Sun et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target

(2009) Agnieszka K. Witkiewicz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Cytokeratin Profile in Basal Cell Carcinoma

(2008) Elvio Alessi et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway

(2008) Helen J. Ball et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

New Concepts for Basal Cell Carcinoma. Demographic, Clinical, Histological Risk Factors, and Biomarkers. A Systematic Review of Evidence Regarding Risk for Tumor Development, Susceptibility for Second Primary and Recurrence

(2008) Athanassios Kyrgidis et al.   JOURNAL OF SURGICAL RESEARCH

Skin cells, but not T cells, are resistant to indoleamine 2, 3-dioxygenase (IDO) expressed by allogeneic fibroblasts

(2008) Farshad Forouzandeh et al.   WOUND REPAIR AND REGENERATION